Novartis (NVS) Earnings Analysis

Novartis (NVS) next reports earnings on 2026-10-27, consensus EPS 2.26 USD. Last quarter (2026-07-21) it beat with EPS 2.41 USD vs 2.17 USD est (+11.1%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 23.23.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NVS next report earnings?

Next earnings date2026-10-27
Consensus EPS estimate2.26 USD
Revenue estimate14.57B

NVS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-212.41 USD2.17 USD+11.1%Beat
2026-02-042.03 USD1.99 USD+2%Beat
2025-07-172.42 USD2.38 USD+1.7%Beat
2025-01-311.98 USD1.8 USD+10%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

NVS valuation and analyst view

Trailing P/E23.23
Trailing EPS6.641 USD
Price / book7.00
Dividend yield2.97%
Market cap291.98B
Analyst consensusHold (6 buy / 17 hold / 2 sell)
Avg price target137.75 USD

Related research pages

Frequently asked questions

When is Novartis (NVS)'s next earnings date?

Novartis is next scheduled to report on 2026-10-27, with a consensus EPS estimate of 2.26 USD and revenue estimate of 14.57B.

Did NVS beat earnings last quarter?

In its 2026-07-21 report, NVS posted EPS of 2.41 USD versus a 2.17 USD estimate — a beat of 11.1%.

What is NVS's earnings track record?

Over the last 4 reported quarters with consensus data, NVS beat estimates 4 times (100%).

What is NVS's current P/E ratio and EPS?

NVS trades at a trailing P/E of 23.23 on trailing EPS of 6.640725984251969 USD.

What do analysts rate NVS?

Analyst consensus is "Hold" across 25 ratings (0 strong buy, 6 buy, 17 hold, 2 sell, 0 strong sell). Average 12-month price target: 137.75 USD.